Orphazyme A/S

📍 Denmark🗓 Founded 2009👥 12 employees💰 Last funded Mar 2021
Biotechnology🌐 orphazyme.com
Website LinkedIn
Orphazyme is a global biopharmaceutical company, headquartered in Denmark, with a rapidly growing presence in the United States. We are pioneering a new kind of treatment, applying our specialized expertise to bring innovative therapies to patients with neurodegenerative orphan diseases. With a late-stage drug pipeline, we are relentless in our commitment to advancing treatments and making a profound impact for those touched by these rare, serious diseases. Today we are listed on Nasdaq Copenhagen (TICKER: ORPHA.CO) and Nasdaq U.S. (TICKER: ORPH), and are expanding our global presence with offices in Denmark, Switzerland, and our US headquarters in Chicago. See our community guidelines: bit.ly/3uapRYr
3
Total investors
1
Early stage
0
Mid stage
0
Late stage
2009
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
2
Netherlands
1
Investor activity2011–2021 · investors recorded per year
2011120212
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Orphazyme A/S?
Orphazyme A/S has 3 investors on record on gritt.io, including 1 early-stage backers.
When did Orphazyme A/S last raise funding?
The most recent investment in Orphazyme A/S recorded on gritt.io was in March 2021.
When was Orphazyme A/S founded?
Orphazyme A/S was founded in 2009.
What industry is Orphazyme A/S in?
Orphazyme A/S operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Orphazyme A/S based?
Orphazyme A/S is headquartered in Denmark.